Cargando…
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
Prognostic value of hematologic indices and their association with the tumor microenvironment (TME) remain unclear in advanced soft tissue sarcoma (STS). We aimed to evaluate their prognostic value and correlation with the TME status in advanced STS treated with first-line doxorubicin (DXR) therapy....
Autores principales: | Watanabe, Sho, Shimoi, Tatsunori, Nishikawa, Tadaaki, Kawachi, Asuka, Okuma, Hitomi Sumiyoshi, Tokura, Momoko, Yazaki, Shu, Mizoguchi, Chiharu, Arakaki, Motoko, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Kojima, Yuki, Sudo, Kazuki, Noguchi, Emi, Yoshida, Akihiko, Kawai, Akira, Fujiwara, Yasuhiro, Yonemori, Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318000/ https://www.ncbi.nlm.nih.gov/pubmed/37400504 http://dx.doi.org/10.1038/s41598-023-37616-w |
Ejemplares similares
-
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022) -
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
por: Sanomachi, Tomomi, et al.
Publicado: (2023) -
Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
por: Yazaki, Shu, et al.
Publicado: (2022) -
Changes in HER3 expression profiles between primary and recurrent gynecological cancers
por: Kojima, Yuki, et al.
Publicado: (2023) -
Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment
por: Watanuki, Rurina, et al.
Publicado: (2020)